According to Apollo Endosurgery's latest financial reports the company has a price-to-book ratio of 17.8.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 9.82 | 80.3% |
2021-12-31 | 5.44 | -58.13% |
2020-12-31 | 13.0 | -53.77% |
2019-12-31 | 28.1 | 973.27% |
2018-12-31 | 2.62 | 35.09% |
2017-12-31 | 1.94 | -36.76% |
2016-12-31 | 3.07 | 329.28% |
2015-12-31 | 0.7146 | -79.15% |
2014-12-31 | 3.43 | -40.09% |
2013-12-31 | 5.72 | 29.26% |
2012-12-31 | 4.43 | -96.14% |
2011-12-31 | 115 | 541.4% |
2010-12-31 | 17.9 | -21.02% |
2009-12-31 | 22.6 | 46.11% |
2008-12-31 | 15.5 | -6.19% |
2007-12-31 | 16.5 | |
2006-12-31 | N/A | |
2005-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Merit Medical MMSI | 3.72 | -79.07% | ๐บ๐ธ USA |
Inari Medical
NARI | 5.25 | -70.48% | ๐บ๐ธ USA |